Income Statement Clarivate Plc

Stocks

CLVT

JE00BJJN4441

Professional Information Services

Market Closed - NYSE Other stock markets 21:00:03 17/07/2026 BST			5-day change	1st Jan Change
2.390 ^USD	-0.42%		+7.17%	-28.44%

07-06	Healthcare Stocks Decline as Investors Rotate Away from Safety -- Healthcare Roundup	DJ
07-06	Altaris, LLC entered into a definitive agreement to acquire Life Sciences & Healthcare Business from Clarivate Plc (NYSE : CLVT) for $600 million.	CI

d453b98.pu0G0gfEB0gAJ_-WpLikPubOCpX-jYztETcFjv0NUZI.94h2vVWoSRF6cL3Mzu_NVq2mRM2kwcvYc3Uzy5RXGMbvp2Skc4VAEnNBjA

Published financial data: CLARIVATE PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.88B	2.66B	2.63B	2.56B	2.46B
Total Revenues	1.88B	2.66B	2.63B	2.56B	2.46B
Cost of Goods Sold, Total	626M	954M	906M	869M	834M
Gross Profit	1.25B	1.71B	1.72B	1.69B	1.62B
Selling General & Admin Expenses, Total	643M	730M	740M	728M	709M
Stock-Based Compensation (IS)	-	-	-	-	-
Depreciation & Amortization - (IS)	14M	710M	708M	727M	757M
Amortization of Goodwill and Intangible Assets - (IS)	524M	-	-	-	-
Other Operating Expenses	7.89M	-900K	-300K	-1.3M	-16.3M
Other Operating Expenses, Total	1.19B	1.44B	1.45B	1.45B	1.45B
Operating Income	62.1M	266M	275M	234M	172M
Interest Expense, Total	-252M	-270M	-294M	-283M	-265M
Net Interest Expenses	-252M	-270M	-294M	-283M	-265M
Currency Exchange Gains (Loss)	-19.62M	45.4M	-38.9M	-4.2M	-34.9M
Other Non Operating Income (Expenses)	81.32M	207M	15.9M	5.2M	-
EBT, Excl. Unusual Items	-129M	248M	-42M	-48.2M	-128M
Restructuring Charges	-129M	-66.7M	-40M	-19.6M	-50.7M
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-4.45B	-848M	-466M	-
Gain (Loss) On Sale Of Assets	-	278M	-	54.7M	-
Asset Writedown	-	-	-132M	-75M	-15M
Legal Settlements	-	-	49.4M	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-258M	-3.99B	-1.01B	-554M	-194M
Income Tax Expense	12.3M	-28.9M	-101M	82.9M	7.2M
Earnings From Continuing Operations	-270M	-3.96B	-911M	-637M	-201M
Net Income to Company	-270M	-3.96B	-911M	-637M	-201M
Net Income - (IS)	-270M	-3.96B	-911M	-637M	-201M
Preferred Dividend and Other Adjustments	41.51M	75.4M	75.4M	31.3M	-
Net Income to Common Incl Extra Items	-312M	-4.04B	-987M	-668M	-201M
Net Income to Common Excl. Extra Items	-312M	-4.04B	-987M	-668M	-201M
Per Share Items
Net EPS - Basic	-0.49	-5.97	-1.47	-0.96	-0.3
Basic EPS - Continuing Operations	-0.49	-5.97	-1.47	-0.96	-0.3
Basic Weighted Average Shares Outstanding	631M	676M	672M	694M	673M
Net EPS - Diluted	-0.61	-6.24	-1.47	-0.96	-0.3
Diluted EPS - Continuing Operations	-0.61	-6.24	-1.47	-0.96	-0.3
Diluted Weighted Average Shares Outstanding	641M	679M	672M	694M	673M
Normalized Basic EPS	-0.13	0.23	-0.04	-0.04	-0.12
Normalized Diluted EPS	-0.13	0.23	-0.04	-0.04	-0.12
Payout Ratio	-6.98	-1.9	-8.29	-5.92	-
Supplemental Items
EBITDA	600M	977M	983M	961M	929M
EBITA	586M	942M	960M	942M	907M
EBIT	62.1M	266M	275M	234M	172M
EBITDAR	631M	1.01B	1.01B	986M	956M
Effective Tax Rate - (Ratio)	-4.76	0.72	10	-14.97	-3.71
Current Domestic Taxes	4.37M	9.7M	-1.2M	2.3M	3.1M
Current Foreign Taxes	25.29M	-6.4M	-24M	58.9M	45.4M
Total Current Taxes	29.67M	3.3M	-25.2M	61.2M	48.5M
Deferred Domestic Taxes	-8.25M	2.2M	-400K	800K	1.9M
Deferred Foreign Taxes	-9.12M	-34.4M	-75.7M	20.9M	-43.2M
Total Deferred Taxes	-17.37M	-32.2M	-76.1M	21.7M	-41.3M
Normalized Net Income	-80.43M	155M	-26.25M	-30.12M	-80.12M
Interest on Long-Term Debt	98K	1.2M	2.1M	2.1M	-
Non-Cash Pension Expense	14K	0	-	-	-
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Net Rental Expense, Total	30.97M	30.8M	28.4M	25M	26.9M
Imputed Operating Lease Interest Expense	13.53M	12.43M	13.46M	12.05M	12.58M
Imputed Operating Lease Depreciation	17.44M	18.37M	14.94M	12.95M	14.32M
Stock-Based Comp., COGS (Total)	-	36.3M	39.9M	14.6M	17.4M
Stock-Based Comp., SG&A Exp. (Total)	-	65.9M	69M	46M	45.6M
Stock-Based Comp., Other (Total)	33.33M	-	100K	-	100K
Total Stock-Based Compensation	33.33M	102M	109M	60.6M	63.1M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	431M	349M	371M	285M	317M
Trading Asset Securities, Total	-	-	4.1M	-	3.2M
Total Cash And Short Term Investments	431M	349M	375M	285M	320M
Accounts Receivable, Total	906M	872M	908M	798M	822M
Total Receivables	906M	872M	908M	798M	822M
Prepaid Expenses	76.55M	89.4M	88.5M	85.9M	94.2M
Restricted Cash	157M	8M	-	10.5M	12.6M
Other Current Assets, Total	66.65M	76.9M	90.6M	65.2M	61.7M
Total Current Assets	1.64B	1.4B	1.46B	1.24B	1.31B
Gross Property Plant And Equipment	238M	211M	180M	196M	200M
Accumulated Depreciation	-68.17M	-97.2M	-73.6M	-89.2M	-100M
Net Property Plant And Equipment	170M	113M	107M	107M	99.3M
Long-term Investments	-	-	17.7M	14.7M	1.8M
Goodwill	7.9B	2.88B	2.02B	1.57B	1.57B
Other Intangibles, Total	10.39B	9.44B	9.01B	8.44B	8.01B
Deferred Tax Assets Long-Term	27.94M	24.2M	46.7M	48.5M	17.2M
Deferred Charges Long-Term	17.11M	15.5M	23.8M	21.4M	18.7M
Other Long-Term Assets, Total	33.6M	82.4M	19.3M	46.1M	47.6M
Total Assets	20.18B	13.94B	12.71B	11.49B	11.07B
Liabilities
Accounts Payable, Total	129M	101M	144M	124M	151M
Accrued Expenses, Total	572M	484M	434M	343M	349M
Current Portion of Long-Term Debt	27.46M	1M	-	-	100M
Current Portion of Leases	35.29M	25.7M	25.6M	21.9M	19.9M
Current Income Taxes Payable	28.54M	-	-	-	-
Unearned Revenue Current, Total	1.03B	948M	983M	859M	879M
Other Current Liabilities	79.01M	-	13.2M	84.8M	70.9M
Total Current Liabilities	1.9B	1.56B	1.6B	1.43B	1.57B
Long-Term Debt	5.43B	5B	4.69B	4.49B	4.3B
Long-Term Leases	122M	72.9M	92.3M	81.2M	64.5M
Unearned Revenue Non Current	54.25M	38.5M	38.7M	16.6M	17M
Pension & Other Post Retirement Benefits	13.69M	9.9M	-	-	-
Deferred Tax Liability Non Current	380M	316M	250M	273M	212M
Other Non Current Liabilities	355M	130M	41.9M	55.9M	65.6M
Total Liabilities	8.26B	7.13B	6.71B	6.35B	6.23B
Preferred Stock Convertible	1.39B	1.39B	1.39B	-	-
Total Preferred Equity	1.39B	1.39B	1.39B	-	-
Common Stock, Total	11.83B	11.74B	11.74B	12.98B	12.81B
Additional Paid In Capital	-	-	-	-	-
Retained Earnings	-1.6B	-5.66B	-6.65B	-7.31B	-7.51B
Treasury Stock	-16.96M	-	-	-	-
Comprehensive Income and Other	327M	-666M	-495M	-526M	-453M
Total Common Equity	10.53B	5.42B	4.6B	5.14B	4.84B
Total Equity	11.93B	6.81B	5.99B	5.14B	4.84B
Total Liabilities And Equity	20.18B	13.94B	12.71B	11.49B	11.07B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	683M	674M	666M	692M	641M
ECS Total Common Shares Outstanding	683M	674M	666M	691M	641M
Book Value / Share	15.43	8.04	6.91	7.43	7.56
Tangible Book Value	-7.76B	-6.89B	-6.43B	-4.87B	-4.73B
Tangible Book Value Per Share	-11.37	-10.22	-9.65	-7.04	-7.39
Total Debt	5.61B	5.1B	4.81B	4.59B	4.48B
Net Debt	5.18B	4.76B	4.44B	4.31B	4.16B
Debt Equivalent of Unfunded Proj. Benefit Obligation	14.76M	11M	-	-	-
Debt Equivalent Oper. Leases	248M	246M	227M	200M	215M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	80.22M	84.1M	99M	111M	122M
Full Time Employees	11.1K	11.6K	12K	12K	12K
Part Time Employees	258	200	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	6.71M	27.1M	26.6M	16.2M	11.9M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-270M	-3.96B	-911M	-637M	-201M
Depreciation & Amortization - CF	14M	35.2M	23.2M	19M	21.9M
Amortization of Goodwill and Intangible Assets - (CF)	524M	675M	685M	708M	735M
Depreciation & Amortization, Total	538M	710M	708M	727M	757M
Amortization of Deferred Charges, Total - (CF)	13.17M	16.4M	18.2M	16.4M	14.3M
(Gain) Loss From Sale Of Asset	-	-278M	-	-54.7M	-
(Gain) Loss on Sale of Investments - (CF)	-	-	6.1M	-	-
Asset Writedown & Restructuring Costs	48.15M	4.48B	980M	540M	18.6M
Stock-Based Compensation (CF)	33.33M	93.9M	109M	59.9M	63.1M
Provision and Write-off of Bad Debts	5.99M	-	-	-	-
Other Operating Activities, Total	-112M	-279M	-106M	19.3M	-27.1M
Change In Accounts Receivable	-64.07M	-28.3M	-25.5M	92.6M	-5M
Change In Accounts Payable	31.19M	-24M	41.2M	-15M	22.8M
Change in Unearned Revenues	207K	-9.3M	20.3M	-106M	-2.6M
Change in Other Net Operating Assets	101M	-210M	-96.4M	3.7M	-11.7M
Cash from Operations	324M	509M	744M	647M	628M
Capital Expenditure	-119M	-203M	-242M	-289M	-263M
Cash Acquisitions	-3.93B	-24.8M	-5.4M	-32M	-
Divestitures	4.3M	285M	10.5M	84.4M	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Cash from Investing	-4.04B	57.3M	-237M	-237M	-263M
Long-Term Debt Issued, Total	2.18B	-	-	-	500M
Total Debt Issued	2.18B	-	-	-	500M
Long-Term Debt Repaid, Total	-186M	-498M	-301M	-199M	-601M
Total Debt Repaid	-186M	-498M	-301M	-199M	-601M
Issuance of Common Stock	886M	6.6M	500K	-	-
Repurchase of Common Stock	-184M	-190M	-121M	-216M	-235M
Issuance of Preferred Stock	1.39B	-	-	-	-
Preferred Dividends Paid	-18.87M	-75.4M	-75.5M	-37.7M	-
Common & Preferred Stock Dividends Paid	-18.87M	-75.4M	-75.5M	-37.7M	-
Other Financing Activities, Total	-32.62M	-2.1M	100K	-17.5M	-6.9M
Cash from Financing	4.03B	-759M	-496M	-470M	-343M
Foreign Exchange Rate Adjustments	3.74M	-38.2M	3.6M	-15.3M	11.8M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	315M	-231M	13.9M	-75.5M	34M
Supplemental Items
Cash Interest Paid	182M	252M	274M	265M	256M
Cash Income Tax Paid (Refund)	33.87M	63.7M	42.9M	52.9M	42.1M
Levered Free Cash Flow	510M	478M	570M	449M	520M
Unlevered Free Cash Flow	655M	630M	735M	610M	672M
Change In Net Working Capital	-164M	146M	11M	35.3M	-7M
Net Debt Issued / Repaid	1.99B	-498M	-301M	-199M	-101M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	0.22	0.98	1.29	1.21	0.95
Return on Total Capital	0.26	1.13	1.51	1.43	1.13
Return On Equity %	-2.58	-42.27	-14.23	-11.44	-4.03
Return on Common Equity	-3.19	-50.59	-19.69	-13.72	-4.03
Margin Analysis
Gross Profit Margin %	66.64	64.13	65.52	66	66.05
SG&A Margin	34.26	27.44	28.14	28.46	28.86
EBITDA Margin %	31.96	36.72	37.39	37.6	37.85
EBITA Margin %	31.22	35.4	36.51	36.85	36.96
EBIT Margin %	3.31	10.01	10.45	9.16	7.01
Income From Continuing Operations Margin %	-14.41	-148.89	-34.66	-24.9	-8.19
Net Income Margin %	-14.41	-148.89	-34.66	-24.9	-8.19
Net Avail. For Common Margin %	-16.62	-151.73	-37.53	-26.13	-8.19
Normalized Net Income Margin	-4.29	5.83	-1	-1.18	-3.26
Levered Free Cash Flow Margin	27.2	17.95	21.69	17.56	21.18
Unlevered Free Cash Flow Margin	34.9	23.69	27.98	23.84	27.36
Asset Turnover
Asset Turnover	0.11	0.16	0.2	0.21	0.22
Fixed Assets Turnover	11.09	18.78	23.88	23.91	23.79
Receivables Turnover (Average Receivables)	2.28	2.99	2.95	3	3.03
Short Term Liquidity
Current Ratio	0.86	0.89	0.91	0.87	0.84
Quick Ratio	0.7	0.78	0.8	0.76	0.73
Operating Cash Flow to Current Liabilities	0.17	0.33	0.47	0.45	0.4
Days Sales Outstanding (Average Receivables)	159.87	122.03	123.6	122.15	120.42
Average Days Payable Outstanding	61.58	44.11	49.43	56.55	60.23
Long Term Solvency
Total Debt/Equity	47.08	74.93	80.27	89.39	92.57
Total Debt / Total Capital	32.01	42.83	44.53	47.2	48.07
LT Debt/Equity	46.56	74.54	79.84	88.96	90.09
Long-Term Debt / Total Capital	31.65	42.61	44.29	46.97	46.78
Total Liabilities / Total Assets	40.91	51.15	52.84	55.27	56.25
EBIT / Interest Expense	0.25	0.99	0.94	0.83	0.65
EBITDA / Interest Expense	2.5	3.73	3.44	3.48	3.6
(EBITDA - Capex) / Interest Expense	2.03	2.98	2.62	2.46	2.61
Total Debt / EBITDA	8.9	5.07	4.76	4.66	4.69
Net Debt / EBITDA	8.22	4.72	4.39	4.37	4.35
Total Debt / (EBITDA - Capex)	10.96	6.34	6.26	6.59	6.47
Net Debt / (EBITDA - Capex)	10.12	5.91	5.77	6.18	6.01
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	49.67	41.71	-1.17	-2.74	-3.97
Gross Profit, 1 Yr. Growth %	53.42	36.38	0.97	-2.03	-3.91
EBITDA, 1 Yr. Growth %	118.13	62.83	0.63	-2.22	-3.32
EBITA, 1 Yr. Growth %	123.36	60.71	1.93	-1.83	-3.69
EBIT, 1 Yr. Growth %	-320.83	328.82	3.15	-14.74	-26.52
Earnings From Cont. Operations, 1 Yr. Growth %	-22.87	1.36K	-76.99	-30.13	-68.42
Net Income, 1 Yr. Growth %	-22.87	1.36K	-76.99	-30.13	-68.42
Normalized Net Income, 1 Yr. Growth %	-60.44	-292.85	-116.92	14.76	165.98
Diluted EPS Before Extra, 1 Yr. Growth %	-25.25	916.37	-76.44	-34.48	-68.85
Accounts Receivable, 1 Yr. Growth %	22.87	-3.78	4.15	-12.11	2.93
Net Property, Plant and Equip., 1 Yr. Growth %	0.74	-33.22	-5.82	0.28	-7.28
Total Assets, 1 Yr. Growth %	36.46	-30.91	-8.88	-9.57	-3.66
Tangible Book Value, 1 Yr. Growth %	77.32	-11.2	-6.73	-24.29	-2.81
Common Equity, 1 Yr. Growth %	16.59	-48.55	-15.13	11.72	-5.76
Cash From Operations, 1 Yr. Growth %	22.87	57.29	46.12	-13.11	-2.8
Capital Expenditures, 1 Yr. Growth %	10.05	71.22	19.52	19.22	-8.96
Levered Free Cash Flow, 1 Yr. Growth %	25.07	-22.52	16.64	-21.27	15.87
Unlevered Free Cash Flow, 1 Yr. Growth %	38.69	-17.2	14.68	-17.12	10.19
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	38.79	45.63	18.35	-1.96	-3.36
Gross Profit, 2 Yr. CAGR %	41.77	44.65	17.35	-0.54	-2.97
EBITDA, 2 Yr. CAGR %	98.44	88.43	28.01	-0.8	-2.77
EBITA, 2 Yr. CAGR %	102.3	89.43	27.99	0.03	-2.77
EBIT, 2 Yr. CAGR %	13.51	207.85	110.32	-6.22	-20.85
Earnings From Cont. Operations, 2 Yr. CAGR %	2.26	236.09	83.54	-59.9	-53.02
Net Income, 2 Yr. CAGR %	2.26	236.09	83.54	-59.9	-53.02
Normalized Net Income, 2 Yr. CAGR %	-28.78	-12.65	-42.87	-55.93	74.71
Diluted EPS Before Extra, 2 Yr. CAGR %	-19.38	175.64	54.76	-60.71	-54.82
Accounts Receivable, 2 Yr. CAGR %	64.77	8.73	0.1	-4.32	-4.89
Net Property, Plant and Equip., 2 Yr. CAGR %	28.12	-17.99	-20.69	-2.82	-3.58
Total Assets, 2 Yr. CAGR %	130.72	-2.9	-20.65	-9.23	-6.67
Tangible Book Value, 2 Yr. CAGR %	101.72	25.48	-8.99	-15.96	-14.22
Common Equity, 2 Yr. CAGR %	190.45	-22.55	-33.92	-2.63	2.61
Cash From Operations, 2 Yr. CAGR %	65.94	39.03	51.6	12.68	-8.1
Capital Expenditures, 2 Yr. CAGR %	30.29	37.26	43.05	19.37	4.18
Levered Free Cash Flow, 2 Yr. CAGR %	202.25	2.86	-3.82	-4.17	-4.49
Unlevered Free Cash Flow, 2 Yr. CAGR %	107.64	10.56	-1.68	-2.51	-4.44
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	24.68	39.76	27.98	10.85	-2.63
Gross Profit, 3 Yr. CAGR %	32.46	39.95	28.31	10.5	-1.67
EBITDA, 3 Yr. CAGR %	69.75	85.78	52.88	17.02	-1.65
EBITA, 3 Yr. CAGR %	72.96	87.36	54.08	17.16	-1.23
EBIT, 3 Yr. CAGR %	-18.47	76.79	113.82	55.66	-13.54
Earnings From Cont. Operations, 3 Yr. CAGR %	3.75	148.32	37.49	33.02	-62.97
Net Income, 3 Yr. CAGR %	3.75	148.32	37.49	33.02	-62.97
Normalized Net Income, 3 Yr. CAGR %	-18.96	-0.73	-49.46	-27.92	-19.77
Diluted EPS Before Extra, 3 Yr. CAGR %	-18.01	87.63	21.43	16.2	-63.63
Accounts Receivable, 3 Yr. CAGR %	39.86	37.72	7.18	-4.14	-1.96
Net Property, Plant and Equip., 3 Yr. CAGR %	101.9	3.1	-14.12	-14.24	-4.33
Total Assets, 3 Yr. CAGR %	75.88	54.36	-4.94	-17.12	-7.41
Tangible Book Value, 3 Yr. CAGR %	52.46	53.45	13.67	-14.41	-11.79
Common Equity, 3 Yr. CAGR %	115.63	63.13	-20.15	-21.28	-3.68
Cash From Operations, 3 Yr. CAGR %	131.49	63.01	41.35	25.93	7.26
Capital Expenditures, 3 Yr. CAGR %	37.69	42.69	31.07	34.62	9.06
Levered Free Cash Flow, 3 Yr. CAGR %	140.53	104.45	8.1	-10.03	2.09
Unlevered Free Cash Flow, 3 Yr. CAGR %	81.67	60.66	12.58	-7.13	1.55
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	23.72	22.11	21.28	14.38
Gross Profit, 5 Yr. CAGR %	-	26.65	26.2	22.08	14.74
EBITDA, 5 Yr. CAGR %	-	43.17	51.63	44.54	27.57
EBITA, 5 Yr. CAGR %	-	43.38	53.33	45.77	28.16
EBIT, 5 Yr. CAGR %	-	32.15	19.11	37.19	43.69
Earnings From Cont. Operations, 5 Yr. CAGR %	-	71.89	30.35	19.74	-10.52
Net Income, 5 Yr. CAGR %	-	71.89	30.35	19.74	-10.52
Normalized Net Income, 5 Yr. CAGR %	-	3.97	-29.54	-28.26	-16.99
Diluted EPS Before Extra, 5 Yr. CAGR %	-	38.66	5.71	0.39	-18.24
Accounts Receivable, 5 Yr. CAGR %	-	22.37	22.35	19.05	2.18
Net Property, Plant and Equip., 5 Yr. CAGR %	-	37.57	38.92	0.69	-10.05
Total Assets, 5 Yr. CAGR %	-	28.34	27.92	24.83	-5.63
Tangible Book Value, 5 Yr. CAGR %	-	25.83	24.03	20.6	1.56
Common Equity, 5 Yr. CAGR %	-	33.33	34.36	32.71	-11.73
Cash From Operations, 5 Yr. CAGR %	-	138.02	95.44	40.62	18.99
Capital Expenditures, 5 Yr. CAGR %	-	39.94	39.8	32.86	19.57
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	73.1	51.7	2.88
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	46.43	32.03	5.44